Surgical Sciences Skip Menu Welcome Faculty Faculty Labs Modis Lab Murton Lab Transplant Research Group Research Areas Burns, Trauma & Critical Care Cancer Gastrointestinal Disease Metabolic Physiology Outcomes Pediatric Surgery Transplant Research News News Provectus Biopharmaceuticals Establishes Research Collaboration with University of Texas Medical Branch at Galveston to Investigate Pharmaceutical-Grade Small Molecule Immunotherapy Rose Bengal for Wound Healing October 3, 2022, 08:57 AM by Source: Provectus Biopharmaceuticals Inc. Drs. El Ayadi and Jay plan to examine the safety of topically-applied, multi-dosed RBS over the wound healing periods of inflammation and cellular proliferation, determine the efficacy of RBS in a pre-clinical model of wound healing, and elucidate a spatiotemporal immune activation signature over wound healing time in a large animal model of burn and full-thickness cutaneous trauma. Dr. Williams New Associate CMO for UTMB Clear Lake Campus September 23, 2022, 14:05 PM by UTMB Surgery Congratulations to Urology Division Chief Stephen Williams, MD, MBA, MS, FACS, for becoming the Associate Chief Medical Officer for the UTMB Clear Lake Campus! New: BioRender Premium, UTMB Institutional Access July 5, 2022, 15:20 PM by UTMB Surgery The Graduate School for Biomedical Sciences and the Vice President for Research are bringing BioRender Premium to all students, faculty, and staff at The University of Texas Medical Branch! Surgery Graduation, 2022 July 6, 2022, 14:20 PM by UTMB Surgery Congratulations, Graduates! Transplant Team Attends 2022 American Transplant Congress June 30, 2022, 16:15 PM by UTMB Surgery The ATC brings together transplant physicians, scientists, nurses, organ procurement personnel, pharmacists, allied health professionals and other transplant professionals. 1 2 3 4 5 6 7 8
Provectus Biopharmaceuticals Establishes Research Collaboration with University of Texas Medical Branch at Galveston to Investigate Pharmaceutical-Grade Small Molecule Immunotherapy Rose Bengal for Wound Healing October 3, 2022, 08:57 AM by Source: Provectus Biopharmaceuticals Inc. Drs. El Ayadi and Jay plan to examine the safety of topically-applied, multi-dosed RBS over the wound healing periods of inflammation and cellular proliferation, determine the efficacy of RBS in a pre-clinical model of wound healing, and elucidate a spatiotemporal immune activation signature over wound healing time in a large animal model of burn and full-thickness cutaneous trauma.
Dr. Williams New Associate CMO for UTMB Clear Lake Campus September 23, 2022, 14:05 PM by UTMB Surgery Congratulations to Urology Division Chief Stephen Williams, MD, MBA, MS, FACS, for becoming the Associate Chief Medical Officer for the UTMB Clear Lake Campus!
New: BioRender Premium, UTMB Institutional Access July 5, 2022, 15:20 PM by UTMB Surgery The Graduate School for Biomedical Sciences and the Vice President for Research are bringing BioRender Premium to all students, faculty, and staff at The University of Texas Medical Branch!
Transplant Team Attends 2022 American Transplant Congress June 30, 2022, 16:15 PM by UTMB Surgery The ATC brings together transplant physicians, scientists, nurses, organ procurement personnel, pharmacists, allied health professionals and other transplant professionals.